Skip to main content
    H

    HealthStream Inc (HSTM)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $27.68
    -0.25 (-0.91%)

    Market Cap: $855.77M

    Last updated: Nov 17, 2026 at 4:20 PM ET

    HealthStream Inc (HSTM) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    HealthStream (HSTM) has a market cap of $855.77M and an enterprise value of $796.80M. Its trailing P/E of 35.0x is below its 10-year median of 62.4x.

    Total Valuation

    Enterprise value is 6.89% below the market cap, as cash exceeds debt.

    Market Cap$855.77M
    Enterprise Value$796.80M
    Latest price (Nov 17, 2026)$27.68

    Key Dates

    The next earnings report is expected on Feb 22, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Nov 16, 2026.

    Next Earnings DateFeb 22, 2027 (expected)
    Last Earnings DateNov 2, 2026
    Last Ex-Dividend DateNov 16, 2026
    Next Payment DateNov 27, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.89% in the quarter ended Sep 30, 2026 and shrank 1.52% a year over 2 years.

    Shares Outstanding29.49M
    Shares Change (YoY)-0.66%
    Shares Change (QoQ)+0.89%
    Share Count Growth (2Y CAGR)-1.52%

    Valuation Ratios

    Sales and book value multiples are 2.5x and 2.0x. Its year-end P/E ranged from 33.0x to 131.8x from 2016 to 2025.

    P/E Ratio35.0x
    Forward P/E36.7x
    P/S Ratio2.5x
    Forward P/S2.6x
    P/B Ratio2.0x
    P/TBV Ratio9.5x
    P/FCF Ratio19.8x
    P/OCF Ratio12.0x
    PEG Ratio3.2

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 9.1x EBITDA and 18.4x free cash flow.

    EV / Earnings38.9x
    EV / Sales2.4x
    EV / EBITDA9.1x
    EV / FCF18.4x

    Price Statistics

    The stock is up 12.98% over 52 weeks and trades 10.80% below its 50-day average.

    Beta (1Y)0.40
    52-Week Change+12.98%
    1-Month Change-16.34%
    3-Month Change-2.79%
    6-Month Change+16.64%
    5-Year Change+26.64%
    10-Year Change+24.95%
    Total Return (1Y)+13.67%
    Total Return (3Y CAGR)+3.33%
    Total Return (5Y CAGR)+2.12%
    Return vs SPY (1Y)+2.53%
    Max Drawdown (1Y)-22.55%
    Max Drawdown (3Y)-41.70%
    Sharpe Ratio (1Y)0.39
    Correlation with SPY (1Y)0.16
    50-Day Average$31.03
    200-Day Average$25.97
    52-Week Range$19.39 to $35.57
    RSI (14 Days)29.3
    Average Volume (20 Days)249.74K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.48x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio1.48x
    Quick Ratio1.48x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is 5.10% over the last 12 months, against a 5-year average of 4.11%.

    Return on Equity (ROE)5.10%
    Return on Assets (ROA)3.62%
    ROE (5Y Average)4.11%
    ROA (5Y Average)2.82%
    ROIC (5Y Average)4.44%
    Asset Turnover0.62x
    Receivables Turnover8.68x

    Taxes

    Income tax took 22.50% of pretax income over the last 12 months.

    Income Tax (TTM)$5.95M
    Effective Tax Rate22.50%

    Scores

    HSTM has an Altman Z-Score of 4.18, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score4.18
    Altman Z ZoneSafe
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $327.95M over the last 12 months is up 9.83% from the 12 months before.

    Revenue$327.95M
    Revenue Growth (YoY)+9.83%
    Gross Profit$212.32M
    Operating Income$24.82M
    Pretax Income$26.44M
    Net Income$20.49M
    EBITDA$83.21M
    Reported EPS (TTM)$0.79

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 71.03% of the $565.85M in total assets.

    Cash and Equivalents$58.96M
    Total Debt$0
    Net Cash$58.96M
    Net Cash Per Share$2.00
    Working Capital$58.17M
    Shareholder Equity$401.94M
    Book Value Per Share$13.63
    Tangible Book Value$85.80M
    Tangible Book Per Share$2.91
    Total Assets$565.85M
    Total Liabilities$163.91M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $29.90M of capital spending, operating cash flow left $41.25M of free cash flow.

    Operating Cash Flow$71.15M
    Capital Expenditures$29.90M
    Free Cash Flow$41.25M
    FCF Per Share$1.35
    Depreciation and Amortization$58.84M
    Dividends Paid$3.99M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 7.57%, against a 5-year average of 5.50%.

    Gross Margin64.74%
    Operating Margin7.57%
    Pretax Margin8.06%
    Net Margin6.25%
    EBITDA Margin25.37%
    FCF Margin12.58%
    Gross Margin (5Y Average)65.50%
    Operating Margin (5Y Average)5.50%
    Net Margin (5Y Average)5.03%

    Growth

    Revenue grew 4.45% a year over 3 years, and EPS 32.64% a year.

    Revenue Growth (3Y CAGR)+4.45%
    Revenue Growth (5Y CAGR)+4.43%
    EPS Growth (3Y CAGR)+32.64%
    EPS Growth (5Y CAGR)+16.23%
    FCF Growth (3Y CAGR)+6.10%
    FCF Growth (5Y CAGR)+12.79%
    Operating Income Growth (3Y CAGR)+17.58%
    Book Value Per Share Growth (2Y CAGR)+3.23%
    Tangible Book Per Share Growth (2Y CAGR)-19.06%

    Revenue and profit by year

    Dividends and Yields

    HSTM pays out 7.09% of earnings as dividends.

    Dividend Per Share (Annual)$0.14
    Dividend Yield0.51%
    Payment ScheduleQuarterly
    Payout Ratio7.09%
    FCF Payout Ratio9.68%
    Earnings Yield2.86%
    FCF Yield5.05%
    Buyback Yield1.75%
    Shareholder Yield2.24%

    Full dividend history

    Peer Position

    Against 7 similar companies, HSTM has the 3rd highest P/E.

    P/E Ratio35.0x vs 16.9x median
    P/S Ratio2.5x vs 1.5x median
    Revenue Growth (Trailing 4 Quarters, YoY)+9.83% vs +13.49% median
    Dividend Yield0.51% vs 0.00% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 6.76% and EPS growth at 14.64% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+6.76%
    EPS Growth Forecast (2Y CAGR)+14.64%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About HSTM

    What is HSTM's market cap?

    HealthStream has a market cap of $855.77M. Its enterprise value, which adds debt and subtracts cash, is $796.80M.

    What is HSTM's P/E ratio?

    HealthStream has a trailing P/E ratio of 35.0x and a forward P/E of 36.7x.

    How many shares of HSTM are outstanding?

    HealthStream has 29.49M shares outstanding. The count is down 0.66% from a year earlier.

    Does HSTM pay a dividend?

    Yes. HealthStream pays $0.14 a share a year, a dividend yield of 0.51%.

    How much debt does HSTM have?

    HealthStream has $0 of total debt and $58.96M of cash and equivalents, a net cash position of $58.96M.